1
Clinical Trials associated with Etanercept biosimilar(Zenotech Laboratories Ltd.)A Multicenter, Randomized, Placebo and Active Comparator-controlled Clinical Trial to Study the Efficacy, Safety and Pharmacokinetics (PK) of Tildrakizumab in Pediatric Subjects From 6 to <18 Years of Age With Moderate to Severe Chronic Plaque Psoriasis
The study has been designed with three components. Part A is an open label PK study followed by a randomized trial component (Part B) followed by open label Long Term Extension (LTE).
The initial PK analysis is first done in adolescent subjects (12 to <18 years) before initiating the PK study in younger cohort (6 to <12 years)
100 Clinical Results associated with Etanercept biosimilar(Zenotech Laboratories Ltd.)
100 Translational Medicine associated with Etanercept biosimilar(Zenotech Laboratories Ltd.)
100 Patents (Medical) associated with Etanercept biosimilar(Zenotech Laboratories Ltd.)
100 Deals associated with Etanercept biosimilar(Zenotech Laboratories Ltd.)